FDA Approves First Treatment for MAS in Still Disease ...Middle East

Emapalumab is approved for both adults and pediatric (newborn and older) patients with MAS in Still disease with an inadequate response or intolerance to glucocorticoids, or with recurrent MAS. Medscape Medical News

Hence then, the article about fda approves first treatment for mas in still disease was published today ( Monday 30/06/2025 - 08:56 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves First Treatment for MAS in Still Disease )

Also on site :

• Trump’s Christmas Eve calls with children asking about Santa’s whereabouts are steeped in partisan politics
• Update: Flood watch affecting 5 Freeway north of LA until early Friday evening caused by persistent downpours
• Ukraine-Russia war latest: Zelensky awaits Putin response to new peace plan while Christmas Eve blast kills 3 in Moscow